Molecule Details
| InChIKey | XPRDUGXOWVXZLL-UHFFFAOYSA-N |
|---|---|
| Compound Name | Vidofludimus |
| Canonical SMILES | COc1cccc(-c2ccc(NC(=O)C3=C(C(=O)O)CCC3)c(F)c2)c1 |
| Clinical Status | Clinical Multi-Target |
| Targets (Human+Pathogen) | 4 |
| Pfam Stratification | Cross-Family |
| Avg pChEMBL | 6.36 |
| Source | ChEMBL;BindingDB;TTD_MultiTarget |
2D Structure
Activity Profile
DrugBank Annotations
| DrugBank ID | DB15446 |
|---|---|
| Drug Name | Vidofludimus |
| CAS Number | 717824-30-1 |
| Groups | investigational |
| ATC Codes | nan |
| Description | Vidofludimus is under investigation in clinical trial NCT03722576 (Vidofludimus Calcium for Primary Sclerosing Cholangitis). |
Categories: Acids, Acyclic Benzene Derivatives
Cross-references: BindingDB: 16111 CHEMBL197194 ChemSpider: 7995757 PDB: D5H ZINC: ZINC000014960644
Target Activities (4)
| Target | Gene | Organism | Category | Pfam | pChEMBL | Type | Source |
|---|---|---|---|---|---|---|---|
| Q02127 | DHODH | Homo sapiens | Human | PF01180 | 6.4 | IC50 | ChEMBL;BindingDB |
| P43354 | NR4A2 | Homo sapiens | Human | PF00104 PF00105 | 6.2 | Kd | ChEMBL |
| Q16552 | IL17A | Homo sapiens | Human | PF06083 | Clinical | TTD_MultiTarget | TTD_MultiTarget |
| E5KIY2 | blaNDM-1 | Escherichia coli | Pathogen | PF00753 | 6.5 | Kd | ChEMBL |
DrugBank Target Actions (1)
| Target | Gene | Target Name | Action | Type |
|---|---|---|---|---|
| Q02127 | DHODH | Dihydroorotate dehydrogenase (quinone), mitochondrial | modulator | targets |